Evolv Technologies Holdings

AI Security Screening Will Face Overwhelming Regulatory And Pricing Headwinds

AN

AnalystLowTarget

Not Invested

Community Contributor

Published

09 Aug 25

Updated

02 Jun 26

Views

57

02 Jun

US$6.32

AnalystLowTarget's Fair Value

US$10.00

36.8% undervalued

1Y

19.2%

7D

-2.9%

Loading

1Y

19.2%

7D

-2.9%

You can edit this narrative until Jun 3 5:10 AM. Then, changes will post as Updates.

Author's Valuation

US$1036.8% undervalued

AnalystLowTarget Fair Value

Shared on 02 Jun 26

Fair value Increased 5.26%

EVLV: 2026 Contract Manufacturing Ramp Will Drive Long Term Upside

Evolv’s latest quarter looks steadier than the market reaction suggests, and analysts are increasingly focused on whether a manufacturing ramp can unlock better growth and profits over the next couple of years. The bigger question is whether the company can hit these goals without more headline-driven turbulence or delays in customer rollouts.

0 views

Shared on 03 Apr 26

EVLV: Expanding Stadium And Hospital Contracts Will Drive Long Term Upside

Analysts have modestly adjusted their price target on Evolv Technologies Holdings, keeping fair value at $9.50 while fine tuning assumptions around the discount rate, revenue growth, profit margin, and future P/E to reflect updated views on the company’s risk profile and long term earnings potential. What's in the News Evolv renewed and expanded its subscription agreement with the Houston Astros, upgrading the venue wide deployment at 41,000 seat Daikin Park to Express Gen2 hardware and adding eXpedite bag screening for staff, which brings Evolv’s professional baseball customer count to twelve.

0 views

Shared on 20 Feb 26

EVLV: Venue Partnerships Will Set Up A Breakout Year In 2026

Analysts have adjusted their price targets for Evolv Technologies Holdings slightly, reflecting updated assumptions around discount rates, revenue growth of about 17.85%, profit margins near 8.19%, and a future P/E of roughly 139.15x. These inputs support a refined view of fair value that remains around $9.50 per share.

3 views

Shared on 22 Jan 26

EVLV: ARR Momentum Will Set Up A Breakout Year In 2026

Narrative Update on Evolv Technologies Holdings Analysts have raised their price target on Evolv Technologies Holdings to $10 from $9, citing a recent quarterly performance described as a strong beat and noting expectations that by 2026 annual recurring revenue growth could exceed reported revenue growth. Analyst Commentary The latest price target change to US$10 highlights that some on the Street see upside potential, but even supportive research comes with clear caveats around how the story could play out over the next few years.

3 views

Shared on 14 Dec 25

Fair value Increased 73%

EVLV: ARR Momentum Will Drive A Breakout Year In 2026

Analysts lifted their price target on Evolv Technologies Holdings by $1 to $10, citing a substantial Q3 beat and expectations that accelerating ARR growth will position 2026 as a breakout year. Analyst Commentary While the latest price target increase to $10 reflects optimism around Evolv Technologies Holdings' Q3 performance and medium term growth prospects, not all market observers are uniformly bullish.

1 view

Valuator

Company Info

Notes

AnalystLowTarget Fair Value

US$10

36.8% undervalued

Future estimation in

Revenue

Profit Margin

Future PE

Est. Revenue

$

Forecast revenue growth rate

15.47%

Historical revenue growth rate

38.98%

Electronic Equipment and Components revenue growth rate

0.69%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

8.94%

Calculation

US$17.90m

Earnings '29

x

148.58x

PE Ratio '29

=

US$2.66b

Market Cap '29

US$2.66b

Market Cap '29

/

206.10m

No. shares '29

=

US$12.90

Share Price '29

US$12.90 Share Price '29

Discounted to 2026 @ 8.89% p.a.

=

US$9.99

Fair Value '26